The effect of estradiol on urodilatin production in postmenopausal women

Archives of Gynecology and Obstetrics

Volumn 262, Issue 1-2, 1998, Pages 65-68

  Seeger, H ^a   Armbruster, F P ^a   Mueck, A O ^a   Lippert, T H ^a  

^a Section of Clinical Pharmacology   (Germany)

Author keywords

Estradiol treatment; Postmenopausal women; Urodilatin

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ESTRADIOL; HORMONE; URODILATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HORMONE SUBSTITUTION; HUMAN; KIDNEY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; SODIUM ABSORPTION; TRANSDERMAL DRUG ADMINISTRATION; URINARY EXCRETION; VASODILATATION; WATER ABSORPTION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGED; ATRIAL NATRIURETIC FACTOR; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTMENOPAUSE; VASODILATOR AGENTS;

EID: 0031774428     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040050229     Document Type: Article

References (10)

1. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu J, Eggena P (1986) Biologic effects of transdermal estradiol. N Engl J Med 4: 1615-1620
2. Collins P (1996) Vascular aspects of estrogen. Maturitas 23: 217-226
3. Forssmann WG (1995) Urodilatin (ularitide, INN): a renal natriuretic peptide. Nephron 69: 211-222
4. Lippert TH, Armbruster FP, Seeger H, Mueck AO, Zwirner M, Voelter W (1996) Urinary excretion of relaxin after estradiol treatment of postmenopausal women. Clin Exp Obstet Gynecol 23: 65-69
5. Lippert TH, Filshie GM, Mueck AO, Seeger H, Zwirner M (1996) Serotonin metabolite excretion after postmenopausal estradiol therapy. Maturitas 24: 37-41
6. Mueck AO, Seeger H, Wiesner J, Korte K, Lippert TH (1994) Urinary prostanoids in postmenopausal women after transdermal and oral oestrogen. J Obstet Gynaecol 14: 341-345
7. Mueck AO, Seeger H, Korte K, Haasis R, Lippert TH (1994) Is there any effect of estradiol on the vasodilating NO/cGMP-system? Investigations of the mechanism of cardiovascular protection by estrogen substitution in postmenopausal women. Zentralbl Gynakol 116: 507-511
8. Mueck AO, Seeger H, Armbruster FP, Lippert TH (1997) Urinary excretion of insulin after estradiol treatment of postmenopausal women. Clin Exp Obstet Gynecol 24: 11-13
9. Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA (1985) Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol 152: 1099-1106
10. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG (1988) Isolation and structural analysis of 'urodilatin', a new peptide of the cardiodilatin (ANP) family, extracted from human urine. Klin Wochenschr 66: 752-759